PMI Extends Acceptance Period for Swedish Match Bid

Aug.11.2022
PMI Extends Acceptance Period for Swedish Match Bid
PMI extends Swedish Match offer acceptance period to await EU approval for acquisition.

Phimo International Holdings B.V. (PMI) has extended Swedish Match's acceptance period for its offer to shareholders until October 21, 2022, as the offer is awaiting approval from the European Union.


Photo credit: SergeVo


On May 11th, Philip Morris International (PMI) announced a bid of SEK 161.2 billion ($16.14 billion) through its Dutch subsidiary to acquire Swedish Match. The acceptance period for the offer will begin on June 29, 2022, and was initially set to expire on September 30, 2022. PMI stated in a press release that it has obtained all necessary international approvals for the transaction, pending the merger control approval from the European Commission.


According to customary advance notice discussions with the European Commission, the company believes that the Commission will not complete its review of the transaction before the initial acceptance period expires on September 30. The terms and conditions of the offer remain unchanged, aside from an extension of the acceptance period. The board of Swedish Match has recommended that shareholders accept PMI's proposal, but some shareholders have expressed opposition. Reuters reported earlier this year that Bronte Capital, a Swedish Match shareholder, opposed the acquisition, calling the offer price "unacceptable." Another shareholder also questioned whether Swedish Match's long-term value is reflected in PMI's offer.


Meanwhile, according to reports, Elliott Investment Management has been increasing its stake in Swedish Match and plans to oppose PMI's acquisition of Scandinavian Tobacco Group under current terms. However, according to analyst Mads Rosendal of Danske Bank, it is unlikely that Elliott will be able to acquire a significant enough stake in Swedish Match to independently block the deal.


Statement


This article is compiled from third-party information and is intended for industry exchange and learning purposes only.


This article does not represent the viewpoint of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The translation of this article is solely for industry communication and research purposes.


Due to limitations in translation ability, the translated article may not convey the exact same meaning as the original text. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macao, Taiwan, or foreign-related expressions and positions.


The copyright of compiled information belongs to the original media and authors. If there is any infringement, please contact us to remove it.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

ceshi1111
ceshi1111
Trusted by industry leaders and innovators, ARAC brings unmatched expertise in Modules 5 & 6, including label and claim development, comprehension testing, human factors/usability, and clinical-behavioral research such as actual use and switching studies. These studies generate the robust, real-world evidence needed to evaluate whether products are “Appropriate for the Protection of Public Health” (APPH) -- including randomized experimental longitudinal, actual use, cohort st
Oct.21
Ireland Taoiseach Calls for Phasing Out Vapes as Cabinet Considers Ban on Single-Use Devices
Ireland Taoiseach Calls for Phasing Out Vapes as Cabinet Considers Ban on Single-Use Devices
Taoiseach Micheál Martin said Ireland should work toward eliminating the use of vapes over time, as the Cabinet meets to consider the Public Health (Single-Use Vapes) Bill 2025, proposed by Health Minister Jennifer Carroll MacNeill. The bill would ban the retail sale of single-use vapes six months after it becomes law.
Nov.19 by 2FIRSTS.ai
Russian State Duma Committee supports bill for tobacco and nicotine products market legalization
Russian State Duma Committee supports bill for tobacco and nicotine products market legalization
A bill endorsing a licensing system for tobacco and nicotine products has been recommended in Russia's State Duma.
Nov.14 by 2FIRSTS.ai
Russia’s Health Ministry backs full ban on vapes and nalivaykas
Russia’s Health Ministry backs full ban on vapes and nalivaykas
Russia’s Ministry of Health (Minzdrav) has expressed support for a full ban on vapes and “nalivayka” alcohol outlets, calling it an effective measure to curb harmful habits and improve public health.
Oct.17 by 2FIRSTS.ai
Singapore tightens vape enforcement, mandates rehab for etomidate users
Singapore tightens vape enforcement, mandates rehab for etomidate users
Singapore’s Ministry of Health (MOH) and Health Sciences Authority (HSA) reported that from Sep 1 to Oct 12, 1,339 people were caught for vape-related offences, including 102 found in possession of etomidate-laced vapes.
Oct.17 by 2FIRSTS.ai
UK’s Nationwide Crackdown Seizes 111,000 Illegal Vapes in “Machinize 2” Operation
UK’s Nationwide Crackdown Seizes 111,000 Illegal Vapes in “Machinize 2” Operation
UK police have carried out a nationwide crackdown under Operation Machinize 2, targeting illegal vapes, counterfeit goods, and grey-market businesses. Raids on more than 2,700 premises led to 924 arrests and the seizure of 111,000 illegal vapes, 70kg of cannabis, 4.5m cigarettes, and £10.7m in proceeds.
Nov.11 by 2FIRSTS.ai